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Abstract  
Drug resistance occurrence is a global healthcare concern responsible for the increased morbidity and 
mortality in hospitals, time of hospitalisation and huge financial loss. The failure of the most antibiotics to 
kill “superbugs” poses the urgent need to develop innovative strategies aimed at not only controlling 
bacterial infection but also the spread of resistance. The prevention of pathogen host invasion by 
inhibiting bacterial virulence and biofilm formation, and the utilisation of bactericidal agents with 
different mode of action than classic antibiotics are the two most promising new alternative strategies to 
overcome antibiotic resistance. Based on these novel approaches, researchers are developing different 
advanced materials (nanoparticles, hydrogels, and surface coatings) with novel antimicrobial properties. 
In this review we summarise the recent advances in terms of engineered materials to prevent bacteria 
resistant infections according to the antimicrobial strategies underlying their design. 
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Introduction 
Today, antimicrobial resistance (AMR) infections are responsible for 700 thousand deaths annually with 
an economic burden of, only in the US, over 20 billion dollars per year, and estimations reveal a 
devastating future by 2050 with 10 million deceased per year unless solutions are found (de Kraker and 
Stewardson 2016). In the last decade, AMR infections have spread from predominantly hospital and care 
settings environments towards the wider community, endangering the healthcare advances. Antibiotics 
are crucial in the modern medicine and the loss of effectiveness jeopardizes not only the fight against 
microbial infections such as pneumonia, tuberculosis and malaria, but also turns simple wounds or 
straightforward surgical procedures into a real menace to life (Jasovský and Littmann 2016). Current 
answers to AMR infections result in higher doses of drugs, treatments with toxic side effects, longer 
hospital stays, and increased mortality (Lee and Cho 2013;Ventola 2015). For instance, colistin, an 
antibiotic avoided for many years due to renal and neurological damage, is administered as a last resort 
treatment for patients with resilient Gram-negative bacterial infections (Karaaslan and Çağan 2016).  
The appearance of antibiotic resistances is a naturally occurring phenomenon via natural selection. The 
antibiotic induces the environmental pressure and those bacteria able to survive and replicate will be the 
ones with genes that confer antibiotic resistance. Due to the high bacterial replication rate and ability to 
acquire foreign genetic material coding for resistance determinants through horizontal gene transfer, 
bacteria can rapidly evolve and adapt to the selective antibiotic pressure with a variety of mechanisms 
including i) degradation of antibiotics (e.g. beta-lactamase inactivation of penicillins), ii) modification of 
the drug target (e.g. mutation of the protein rpsL of the 30S ribosomal subunit, which confers resistance 
to streptomycin), and iii) expression of efflux pumps (e.g. AcrAB-TolC pumps which confer resistance to 
multiple antibiotics as quinolone, chloramphenicol, florfenicol, and tetracycline (TET)) (Baucheron and 
Tyler 2004;Carr and Gregory 2005;Frère 1995;Munita and Arias 2016). The current overuse of antibiotics 
has even enhanced the efficacy of these evolving strategies rendering the emergence of bacterial strains 
resistant to the clinically relevant antibiotics. 
Besides these specific resistance mechanisms, bacteria can adhere to surfaces and grow as biofilms that 
are tolerant to very high concentrations of multiple antimicrobials. Biofilms comprise a structured and 
coordinated community of sessile cells embedded within a self-produced extracellular polymeric matrix 
(Saini and Saini 2011). They can occur on foreign objects inserted into the human body (e.g. orthopaedic 
prostheses and catheters) as well as in any place in the body where the host defences are compromised 
(e.g. chronic wounds with impaired blood supply) (Bjarnsholt 2013). Biofilm related infections are 
difficult to treat and frequently require prolonged treatment or alleviate the burden of diseases (Lebeaux 
and Ghigo 2014). The high incidence of these infections is related to the progress of the modern medicine 
and the frequent use of medical devices (Saini and Saini 2011;Shorr and Lodise 2006).  
The importance of AMR has fuelled different research initiatives covering from fast diagnostics tools to 
design of new drugs and advanced materials that tackle bacterial infections and limit the spread of 
resistance. The novel antimicrobial approaches aim either to interfere with bacterial virulence and biofilm 
establishment enhancing clearance by the host immune system, or eliminate the pathogens through 
mechanisms exerting less selective pressure for resistance selection. The present mini review summarises 
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the recent research focus on the development of novel advanced materials, including nanoparticles (NPs), 
hydrogels, surface coatings that meanwhile display antimicrobial activities towards common pathogens 
avoid the appearance of AMR (Figure 1). Unlike previously published reviews focused in a single type of 
advanced antimicrobial material (Pelgrift and Friedman 2013;Wang and Hu 2017), this review compiles 
different innovative antimicrobial materials according to the strategy underlying their design and 
development.  
 
Inhibition of bacterial virulence and biofilm formation  
The virulence of a microorganism refers to the measure of its pathogenicity and is directly related to its 
ability to invade and multiply within the host, avoid the defence mechanisms and cause disease, thanks to 
the generation of different molecules called virulence factors. These bacteria-associated determinants are 
classified in i) adhesion factors (pili, flagellae, adhesins), ii) surface components that prevent 
phagocytosis, iii) enzymes that damage host tissues known as invasins and iv) toxins such as pore-
forming toxins (PFTs) (Baron 1996). Once the pathogenic microorganism has avoided clearance by the 
host immune system and start multiplying, their growth can occur as biofilm. These sessile forms increase 
the resistance of the pathogenic bacteria to not only the host immune system but also to external agents 
such as antibiotics up to 1000 times.  
The AMR context has driven researchers in the development of ways to prevent bacterial virulence and 
growth (as biofilm) without killing, thus avoiding the evolutionary pressure towards resistance 
mechanisms. The inhibition of bacterial virulence and biofilm growth allow the host defence system to 
eliminate non-cooperating (and hence less virulent) bacteria or substantially increase the effect of co-
administered antibiotics at lower dosages (Brackman and Breyne 2016;Hentzer and Givskov 2003). The 
different strategies to suppress the expression of virulence factors and prevent biofilm growth can be 
divided into i) anti-quorum sensing (anti-QS), ii) anti-toxins, and iii) antibiofouling. These strategies 
preclude the design and development of different advanced materials (Figure 1, left side).  
 
Anti-infective materials with anti-quorum sensing activity  
As bacteria multiply, secreted small-molecule signals called autoinducers (AIs) accumulate in the 
extracellular media and once a threshold is reached, recognition of these signals by membrane receptors 
activates a regulatory cascade that controls numerous cellular processes. This phenomenon, known as QS, 
enables single cells to sense the number of bacteria in their environment and when a sufficient number of 
bacteria is reached, turns on collective behaviours, such as expression of virulence factors and formation 
of biofilms. Gram-negative bacteria secrete acyl-homoserine lactones (AHLs) that penetrate into the cells 
and activate the cognate AHL receptor, while Gram-positive bacteria produce autoinducing peptides that 
interact with a transmembrane histidine kinase receptor activating the target gene expression via 
autophosphorylation of the transcriptional regulator (Atkinson and Williams 2009).  
Interruption of QS has become an attractive strategy to suppress the virulence factors secretion and 
biofilm establishment, increasing bacterial susceptibility to lower dosages of conventional antimicrobials 
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and host immune response (Annous and Fratamico 2009;Cvitkovitch and Li 2003;Davies and Parsek 
1998;Galloway and Hodgkinson 2010;Li and Tian 2012;Wang and Morohoshi 2008). Anti-QS 
approaches target the disruption of QS signalling by: i) quorum quenching enzymes (QQE) degrading the 
AIs in the extracellular environment and ii) QS inhibitors (QSI) competing with QS molecules for binding 
to the cognate receptors. QQE, such as acylase and lactonase, selectively inactivate the QS signals in 
Gram-negative bacteria through the hydrolysis of amide bond or lactone ring in the AHLs, respectively 
(Craigen and Dashiff 2011;Johansen and Falholt 1997). Based on these anti-QS strategies, researchers 
have generated novel materials to attenuate bacterial virulence and prevent biofilm formation. In our 
group, the potential of acylase to reduce Pseudomonas aeruginosa biofilm formation on catheters, was 
demonstrated in vitro under conditions mimicking the real situation during catheterisation (Ivanova and 
Fernandes 2015). In another work, the enzyme immobilisation on polyurethane surface resulted also in 
attenuation of P. aeruginosa virulence (Grover and Plaks 2016). Acylase has been used as an anti-biofilm 
agent after chemical and enzymatic immobilisation on carboxylated polyaniline nanofibers (Lee and Lee 
2017). This QQE was also combined with matrix degrading amylase to impart anti-biofilm functionality 
on catheter surface. The enzymes were deposited in multilayered fashion on silicone material and 
demonstrated ability to counteract single and dual species biofilms formation by P. aeruginosa and 
Escherichia coli. The anti-biofilm activity of the coatings was improved by more than 20 % when the 
outermost layer was the QQE, initially affecting bacterial communication. QQE lactonase has been coated 
onto gold NPs to reduce exopolysaccharide production, metabolic activities, and cell surface 
hydrophobicity of multidrug-resistant Proteus species (Vinoj and Pati 2015). This QQE has also been 
immobilised onto magnetic NPs that were also able to hydrolyse AHL and inhibit QS in Gram-negative 
bacteria (Beladiya and Tripathy 2015). Lactonase containing gels inhibited the spread of skin pathogens 
and considerably increased the mice survival after treatment with antibiotic, at very low amounts (Gupta 
and Chhibber 2015). Except the enzymes for QS signals inactivation, other compounds such as antibodies 
and NPs have been engineered to interfere with bacterial virulence. For example, silicon dioxide NPs 
functionalised with β-cyclodextrin demonstrated the ability to quench the signals in Vibrio fisheri 
inhibiting QS regulated genes expression (Miller and Wang 2015). 
 
Innovative anti-QS approaches use analogues of the AIs that recognise and bind with the corresponding 
bacterial receptors in order to obstruct the QS pathways in Gram-positive or Gram-negative bacteria and 
therefore reduce toxins production or biofilms formation (Frei and Breitbach 2012). Several anti-QS 
materials such as nonwoven meshes, tampons or glass surfaces have been coated with cyclic peptides able 
to disrupt Staphylococcus aureus QS. The QS system of S. aureus was inactivated by 95 % when using 
macrocyclic peptide-loaded carboxymethylcellulose materials. In vitro tests have shown that these anti-
QS coatings also prevent the QS-dependent biofilm formation of S. aureus but enabling the normal 
bacterial growth (Kratochvil and Tal-Gan 2015).  
Natural compounds such as heterocyclic organic furanones alter biofilm formation by hindering QS 
process. Red algae Delisea pulchra synthesizes halogenated furanones as secondary metabolite for 
bleaching protection. This organic compound also influences the interspecies QS communication on 
Serratia liquefaciens and Proteus mirabilis altering their biofilm motility (Givskov and de Nys 
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1996;Gram and de Nys 1996). Furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H) produced by 
D. pulchra can also alter the swarming motility and biofilm formation of E. coli by interrupting the QS 
gene regulation (Ren and Sims 2001). Release efficiency of (5Z-)-4-bromo-5-(bromomethylene)-2(5H)-
furanone - loaded poly(L-lactic acid) (PLLA) NPs coated on dental devices have been shown to be 
effective for prevention of peri-implant infection (Cheng and Wu 2012). The immobilisation of this 
furanone loaded PLLA NPs on microarc-oxidised titanium implants also inhibited S. aureus biofilm 
formation in the early and intermediate stages (Cheng and Zhao 2015).  
Synthetic furanones have been designed to improve the otherwise limited effect of the natural furanones 
on the QS system of P. aeruginosa. These new compounds were tested on mice and results showed their 
potential to control bacterial virulence without bactericidal or growth inhibition effect (Wu and Song 
2004). The immobilisation of derivative 3-(1′-bromohexyl)-5-dibromomethylene-2(5 H)-furanone on the 
styrene polymer or catheter surface significantly reduced Staphylococcus epidermidis formation (Hume 
and Baveja 2004). Anti-QS compounds were used to develop solid lipid NPs with improved anti-
virulence activity against P. aeruginosa compared to the free agent (Nafee and Husari 2014). The QSI S-
phenyl-L-cysteine sulfoxide was encapsulated into zein NPs and inhibited Streptococcus mutants biofilm 
growth (Kasper and Hart 2016). The simultaneous application of either QQE or QSI with antibiotics was 
shown to significantly attenuate bacterial virulence and inhibit resistant biofilm formation when 
compared to the active agents alone. This approach opens new avenue for the development of highly 
effective antibacterial and anti-biofilm materials (Brackman and Cos 2011).  
 
Toxin sequestering materials 
Bacterial pathogens produce toxins able to create the optimum conditions for bacterial invasion and 
growth in the host. The role of toxins in damaging the host tissues, for example, via physical disruption, 
or modulating the host immune response, such as up-regulation of cytokine expression, is well established 
as part of the infectious processes. Within the framework of anti-virulence therapy, the removal of 
bacterial offensive weapons is of high interest and despite it has been less explored in comparison to the 
aforementioned strategies, researchers have designed advanced materials with anti-toxin properties. Using 
NPs as decoys for PFTs, scientists have design and produced the so-called “nanosponges”, a polymeric 
NP cores coated with intact red blood cell membranes (Hu and Fang 2013). Thanks to the wrapping 
membrane, these “nanosponges” display an ideal mimicry to absorb a wide range of PFTs regardless of 
their molecular structures. On the other hand, the polymeric core stabilizes the membrane shell and 
prolongs systemic circulation for detoxification in the bloodstream. In further developments, the 
“nanosponges” have been integrated in hydrogels for the effective treatment of localised bacterial 
infection in mouse model through subcutaneous injection (Wang and Gao 2015). Moreover, a recent work 
shows how changing the NPs coating for macrophages membranes allowed the removal of endotoxins, a 
lipopolysaccharide released in sepsis, that bounds to macrophages and induce changes in immune cell 
activity (Thamphiwatana and Angsantikul 2017). Therefore, the membrane-coated NPs open a door to the 
sequestration of different toxins, based on its cell target, as an attractive alternative to prevent infections. 
Nevertheless, the removal of toxins is not limited to the use of NPs with biological component, 
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biocompatible synthetic polymer NPs for instance have showed in vivo binding affinity against melitin, a 
cytolytic peptide from bee venom that forms membrane pores (Henry and Neill 2014). These particles 
were generated from the combinations of hydrophobic, negatively charged and positively charged 
monomer library thus adjusting the ratio of each component for optimum toxin binding. This systematic 
approach shows potential used for the generation of NPs with specific binding against bacterial toxins.  
 
Antibiofouling materials and surfaces 
Indwelling medical devices and implants, once inserted in the human body, create an environment for 
pathogenic bacteria to adhere and establish biofilms, resulting in severe chronic infection with associated 
tissue destruction, as well as systemic dissemination of the pathogen. Bacterial adherence occurs at the so 
called “surface conditioning layer” which is comprised of proteins (e.g. fibronectin, fibrinogen, and 
collagen), lipids, polysaccharides and inorganic salts (Zwaal and Comfurius 1977). The nonspecific 
protein adsorption on the inserted device surface triggers the irreversible bacterial attachment (Denstedt 
and Wollin 1998;Trautner and Darouiche 2004). Upon adhesion, bacteria start to grow and expand, 
forming small functional community of cells of the same species or other bacterial species and 
microorganisms (Hung and Henderson 2009).  
Systematic replacement of the contaminated device is not the best option to prevent biofilm related 
infections, since only provides a new surface for biofilm establishment (Cole and Records 2014). 
However, the functionalisation with broad-spectrum antibacterial agents (e.g. antibiotics, silver and nitric 
oxide), despite being an active field of research (Evliyaoǧlu and Kobaner 2011;Lellouche and Friedman 
2012;Li and Li 2014), implies evolutionary stress for selection of resistant bacteria. For these reasons, the 
design of novel antibacterial and anti-biofilm materials aims to inhibit the initial adherence of the free 
floating cells and consequently prevent the biofilm formation on the surface of the inserted medical 
device.  
Surface roughness, charge, degree of hydrophobicity, Lewis acid-base character and hydrogen-bonding 
capacity are the main factors that influence non-specific reversible microbial attachment, the first step in 
biofilm growth (Tang and Cao 2009). Low surface roughness and hydrophobicity decrease cell 
attachment in different surfaces. Hydrophilic polymers such as poly(ethylene glycol) (PEG), poly(L-
glutamic acid), poly(acrylic acid) (PAA) grafted PEG, heparin and hyaluronic acid (HA), have been used 
to increase the surface hydrophilicity forming a highly hydrated layer that serves as a physical and energy 
barrier for bacterial adherence  (Boulmedais and Frisch 2004;Fu and Ji 2005;Saldarriaga Fernández and 
van der Mei 2007;Schmolke and Demming 2010).  Nanofilms of silver and titanium oxide decreased 
roughness and hydrophobicity of stain steel orthodontic brackets limiting Streptococcus mutans biofilm 
formation (Ghasemi and Arash 2017). Fluoroalkylsilane also reduced S. epidermidis adhesion when 
coated on silicone by reduced roughness and hydrophobicity (Tang and Cao 2009). Although these 
reported studies exhibit higher bacterial adhesion on hydrophobic surfaces, other works have concluded 
that hydrophobic surfaces reduced bacterial adhesion when tested in vivo (Quirynen and Bollen 1995). 
Negatively charged surfaces have been reported to prevent biofilm formation due to electrostatic 
repulsion of the negatively charged bacterial cells. The above-mentioned strategy is feasible for 
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temporary materials such as sutures, meshes, and drainage tubes, but not very practical to control the 
occurrence of implant associated infections (Boudou and Crouzier 2010).  
Recently, zwitterionic polymers have appeared as very promising antifouling materials bearing both 
positively and negatively charged groups (Zhang and Finlay 2009). The adhesion of E. coli and P. 
mirabilis was reduced on silicone coated with zwitterions phosphorylcholines delaying biofilm formation 
compared with uncoated surfaces. The substitution of the phosphorylcholine group by sulfobetaine and 
carboxybetaine has generated antifouling materials able to prevent microbial and protein adhesion (Chen 
and Li 2010;Zhang and Chiao 2015). Immobilisation of zwitterionic poly(carboxybetaine methacrylate) 
on glass material decreased significantly the adhesion of non-specific fibrinogen, preventing P. 
aeruginosa attachment (Cheng and Li 2009). Sulfobetaine polymer brushes prevented bovine serum 
albumin (BSA) adsorption and attachment of E. coli and S. aureus onto a variety of medically relevant 
surfaces (Guo and Jańczewski 2015). Polysulfobetaine coatings on central venous catheters, using a redox 
polymerisation process, have reduced thrombus aggregation and consequent bacterial attachment better 
than unmodified catheter surface (Smith and Zhang 2012). Poly(sulfobetaine methacrylate) (PSBMA), 
polyphenol and tannic acid (TA) coatings have been generated in a multi-layered fashion forming stable 
and protein-resistant materials. These (TA/PSBMA)n layers were stable between pH 4–10, and at 0.05 to 
1 M sodium chloride and urea solutions. Moreover, 20 bilayers of TA and PSBMA were highly 
hydrophilic, reducing the adsorption of BSA, lysozyme and haemoglobin (Ren and Yang 2015). 
However, these zwitterionic coatings easily dissolve in water, limiting their long-term safe applicability. 
The introduction of double bonds into the PSBMA structure has generated a more stable antifouling 
material to coat polyutherane (Wang and Lu 2016). In our group, sulfobetaine metacrylate monomers 
were coated on silicone developing urinary catheters with antifouling properties. This coating prevented 
P. aeruginosa and S. aureus biofilm growth on the urinary catheters longer than their lifetime (Diaz 
Blanco and Ortner 2014). Other strategies involve the degradation of the biofilm extracellular polymeric 
matrix components, weakening and dispersing the biofilm. The observation that different enzymes can 
degrade the matrix components of the biofilm with its subsequent dispersion has revealed potential tools 
to generate antibiofouling and anti-biofilm enzyme based materials (Craigen and Dashiff 2011;Johansen 
and Falholt 1997). In this sense, the enzyme deoxyribonuclease I (DNase I) that degrades the extracellular 
deoxyribonucleic acid (DNA), a key component of P. aeruginosa biofilm matrix, was immobilised on 
ciprofloxacin-loaded poly(lactic-co-glycolic acid) NPs to reduce the mass, size and living cell density in 
P. aeruginosa biofilms (Baelo and Levato 2015). Co-immobilisation of DNase I and the antimicrobial 
peptide (AMP) Palm onto polydimethylsiloxane material, using dopamine chemistry, generated a 
bifunctional antimicrobial and anti-biofilm surface against S. aureus and P. aeruginosa (Alves and 
Magalhães 2016). On the other hand, polysaccharides, another structural component of the biofilm, can 
also be targeted with the use of enzymes. Disersin B from Aggregatibacter actinomycetemcomitans, 
which degrades poly-N-actylglucosamine (Izano and Wang 2007), have been used to generate a silicone 
surface that inhibits the biofilm of two S. epidermidis clinical strains through its layer-by-layer deposition 
(Pavlukhina and Kaplan 2012). Promising anti-biofilm activities against Gram-positive and negative 
pathogenic bacteria, have also been observed using the glycosyl hydrolase (Kalpana and Aarthy 2012).  
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Advanced antibacterial materials  
The discovery of antimicrobial drugs has revolutionised the medicine and changed the paradigm in 
treating severe bacterial infections (Munita and Arias 2016). Their introduction in the clinical practice 
have made possible the complex medical approaches such as cutting edge surgical procedures, solid organ 
transplantation and even management of patients with cancer. However, the antibiotics overuse and 
misuse has led to the appearance of multi-drug resistant pathogens that can survive at unfavourable 
growth conditions, impeding the successful outcomes of critically ill patients (Cantas and Shah 2013). 
The introduction of new antibiotic analogues with similar structural and functional characteristics to the 
original drug is only a short-term antibacterial strategy. Therefore, there is an urgent need of finding an 
alternative solution that relies on more than just the development of next generation antibiotic drugs. In 
this section, special focus is given on the novel antibiotic alternatives for the development of advanced 
materials aimed at killing pathogens via non-specific mechanisms related to membrane damage, oxidative 
stress and interaction with genetic material and protein, reducing the possibility of inducing resistance in 
bacteria. The antibiotic alternatives used to generate the advanced antibacterial materials span from 
molecules such as enzymes or peptides to polymers and more complex nanostructured materials (Figure 
1, right side).  
 
Antibacterial enzymes  
Besides of targeting the degradation or inactivation of essential biofilm components, enzymes may elicit 
antimicrobial activity through the production of hydrogen peroxide, which destroys the invading 
pathogens. In general, hydrogen peroxide kills bacterial cells through peroxidation and disruption of cell 
membranes, oxidation of oxygen scavengers and thiol groups, and disruption of protein synthesis 
(McDonnell and Russell 1999). Hydrogen peroxide-producing enzymes such as glucose oxidase and 
cellobiose dehydrogenase (CDH) can significantly reduce the growth of both Gram-positive and Gram-
negative bacteria and therefore they are widely exploited in the food industry (Ge and Zhao 
2012;Nyanhongo and Sygmund 2013;Walker and Fourgialakis 2007). CDH oxidises cello-
oligosaccharides, which are not considered essential compounds for the pathogens, and produce 
bactericidal hydrogen peroxide. A novel in situ antibacterial approach based on CDH was used to produce 
hydrogen peroxide in presence of cellobiose or other biofilm exopolysaccharides and inhibit bacterial 
growth and biofilm formation on silicone catheters. CDH produced by Myriococcum thermophilum 
inhibited the growth of common urinary pathogens including the multidrug-resistant E. coli, S. aureus, S. 
epidermidis, P. mirabilis, Stenotrophomonas maltophilia, Acinetobacter baumannii and P. aeruginosa in 
presence of cellobiose. CDH combination with glycoside hydrolases demonstrated enhanced 
antimicrobial and anti-biofilm activity by the larger amount of released hydrogen peroxide. The enzyme 
incorporation in lubricants led to significant reduction of bacterial biofilms on catheter surface (Thallinger 
and Argirova 2014). Furthermore, urinary catheters chemically functionalised with antimicrobial CDH, 
resisted S. aureus biofilm formation under static and dynamic conditions. CDH NP-coating onto silicone 
material have been generated in situ using ultrasound sonochemistry to reduce the amount of viable S. 
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aureus cells and the total biomass on urinary catheters (Lipovsky and Thallinger 2015). Myeloperoxidase, 
lactoperoxidase and haloperoxidase are another type of antibacterial enzymes that use hydrogen peroxide 
as a substrate to oxidise halide/pseudohalide to even more active antimicrobials. For instance, horseradish 
peroxidase and glucose oxidase have been incorporated in polyurethane electrospun fibers that inhibited 
the E. coli and S. aureus growth (Amitai and Andersen 2009). However, the enzymes may also contribute 
to the unwanted degradation of biological compounds present in the surrounding of the material.  
Despite the biocide producing enzymes that kill bacteria via other mechanisms have also been reported. 
For examples, lysostaphin is an antibacterial enzyme acting on the cross-linking pentaglycine bridges in 
the Staphylococci cell wall. The enzyme has been immobilised onto a variety of surfaces, which were 
able to kill hospital strains of S. aureus (Yeroslavsky and Girshevitz 2015). Lysostaphin–carbon nanotube 
conjugates have been developed to reduce protein adsorption and bacterial adhesion (Glinel and Thebault 
2012;Pangule and Brooks 2010). Coatings comprised of lysozyme, an antibacterial enzyme that degrades 
the bacterial cell wall, have been designed to inhibit planktonic and sessile growth of Gram-positive and 
Gram-negative bacteria (Minier and Salmain 2005;Muszanska and Busscher 2011;Yuan and Wan 2011). 
Multilayer constructs of lysozyme and negatively charged gold NPs, DNA or pectin inhibited the growth 
of different medically relevant bacterial species (Nepal and Balasubramanian 2008;Zhang and Zhou 
2015;Zhou and Li 2014). Although the enzyme-based antibacterial strategies are very promising, the 
proteins activity after surface immobilisation and their in vivo stability and efficacy is the main concern 
for further clinical application (Chen and Yu 2013).  
 
Antimicrobial peptides  
AMPs are oligopeptides with a broad spectrum antibacterial activity towards bacteria, fungi, viruses, and 
parasites (Bahar and Ren 2013). They interact with negatively charged bacterial cell membrane, cause 
membrane disruption or trans-membrane pore formation and lead to cells lysis and death (Brogden 2005). 
The disruption of bacterial membranes by AMPs is non-specifically and therefore the possibility of 
inducing resistance in bacteria is considerably low. AMPs have been used for development of broad 
spectrum antibacterial materials and surfaces (Chen and Zhu 2017;Costa and Carvalho 2011;Holmberg 
and Abdolhosseini 2013). For instance, polyurethane catheters coated with AMPs inhibited in vivo 
planktonic and sessile forms of Gram-positive and -negative bacteria (Yu and Lo 2017). Antibacterial 
hydrogels with fast jellification and strong adherence to various medical devices or surfaces have been 
engineered using the AMP cateslytin (Mateescu and Baixe 2015). In another study, HA has been 
functionalised with the AMP cateslytin and then used to develop self-defensive multilayer coatings (Cado 
and Aslam 2013). Coating of the broad spectrum AMP, Tet213, have been assembled onto titanium 
surface that demonstrated sustained antimicrobial activity and limited early biofilm formation of both a 
Gram-positive aerobe (S. aureus) and a Gram-negative anaerobe (Porphyromonas gingivalis) for up to 
one month (Shi and Liu 2015). In another study, homopolymer of methacrylamide bearing (oxidised) 3,4-
dihydroxyphenylalanine was used to engineer durable antibacterial-peptide based coatings (Faure and 
Lecomte 2011;Zhu and Jun Loh 2015). Stable antimicrobial coating of cecropin-melittin functionalised 
gold NPs with bactericidal activity towards multi-drug resistant bacteria Gram-positive and -negative 
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bacteria have been reported (Rai and Pinto 2016). Recently, dual coating of AMPs covalently bonded to 
hydroxyapatite surface, followed by deposition of electrostatically bound AMPs has been reported as very 
efficacious in preventing S. aureus, S. epidermidis and P. aeruginosa colonisation, while decreasing the 
side effect to human cells (Townsend and Williams 2017). The main drawbacks limiting the practical 
application of AMPs is their uncontrolled toxicity, ability to affect the eukaryotic cells, high cost for large 
scale synthesis, and rapid degradation by the human proteases (Huang and He 2014).  
 
Cationic Antibacterial Polymers  
Cationic compounds including natural or synthetic polymers and lipids have become very attractive 
antibiotic alternatives in addressing challenges posed by the drug-resistant bacterial infections with 
decreased potential for resistance development. Antimicrobial polymers have been grafted or self-
assembled onto variety of surfaces to interact with the intrinsically anionic bacterial cell wall and cause 
cells death [101]. Chitosan, the naturally occurring cationic polymer, has been applied on silicon wafer as 
chitosan/κ-carrageenan multilayers observing an antibacterial activity against clinically relevant 
Enterococcus faecalis strains (Bratskaya and Marinin 2007). Assemblies of chitosan and anionic lentinan 
sulphate onto polyurethane surface decreased the pathogenic P. aeruginosa growth, without affecting 
human cells viability (Wang and Hong 2012). Functional finishing of cotton fabric via the deposition of 
the oppositely charged chitosan and sodium tripolyphosphate resulted in the successful elimination of 
both Gram-positive and Gram-negative species (Shirvan and Nejad 2014). Nevertheless, the innate 
cationic charge of chitosan, the differences in assembly conditions frequently defines the amount of the 
active agent deposited on the surface, the coating thickness and rigidity, and therefore affects the final 
antibacterial performance of the material. To overcome these drawbacks, quaternary ammonium salts 
bearing positive charge independent on the pH have been introduced to design surfaces with better 
bactericidal properties (Carmona-Ribeiro and de Melo Carrasco 2013;Séon and Lavalle 2015;Tischer and 
Pradel 2012). Quaternary ammonium salt of chitosan have been assembled with PAA on a plasma-treated 
poly(ethylene terephthalate) to eliminate the E. coli and S. aureus (Graisuwan and Wiarachai 2012). 
Quaternary ammonium and/or phosphonium salts of pyridoxine, alanine-derived gemini and fatty acids 
have also been introduced as potent broad spectrum antibiotic alternatives against bacterial pathogens and 
viruses (Bakhshi and Yeganeh 2013;Kayumov and Nureeva 2015;Nikitina and Zeldi 2015;Obłąk and 
Piecuch 2014;Wong and Li 2010).  
Synthetic polyethers, polymethacrylates, polynorbornenes, polycarbonates and poly-β-lactams polymers 
have also been  developed to mimic the structure of the AMPs and kill bacteria (Engler and Tan 2013). 
The introduction of both cationic and hydrophobic moieties into the polymers improves the interaction 
with bacterial cells, leading to irreparable membrane damage and bacterial death (Paslay and Abel 
2012;Smriti Rekha and Ashwani Kumar 2015). Triblock polycarbonate polymers composed of 
antifouling PEG, antimicrobial cationic polycarbonate, and a tethering or adhesive functional block have 
been synthesised and then covalently grafted on catheter surface. Depending on the position of the 
adhesive block, the coatings demonstrated antibacterial and antifouling properties for both Gram-positive 
S. aureus and Gram-negative E. coli under conditions simulating the device lifetime (1 week) (Voo and 
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Khan 2015). Antimicrobial cationic polycarbonate/PEG hydrogels with strong broad-spectrum 
antimicrobial activities against clinically isolated multidrug-resistant microbes have been generated (Liu 
and Yang 2012). The hydrophobicity of the synthetic AMPs mimics is thought to be crucial not only for 
their antimicrobial activity but also for the toxicity to mammalian cells (Timofeeva and Kleshcheva 
2011). Numerous variations in the cationic−hydrophobic balance have been examined aiming to design 
antibacterial compounds. Recently, a very different approach for developing membrane active 
antimicrobials has been reported. This strategy uses spherical and rod-like polymer molecular brushes 
that mimic the two basic structural motifs of bacteriophages. The polymers induced an unusual 
topological transition of bacterial but not mammalian membranes to form pores and as such represent a 
valuable alternative to design advanced materials or surfaces (Jiang and Zheng 2017).  
 
Advanced nanostructured materials  
Nanomaterials including NPs, nanospheres and nanocapsules have been widely used in engineering: i) 
functional coatings of medical devices and surfaces that prevent bacterial infections and promote healing, 
ii) drug carriers for delivering the antibacterial agents at the site of infection and iii) vaccines. The nano-
sized materials possess unique physical and chemical properties and frequently demonstrate improved 
antibacterial features than their bulk counterparts (Wang and Gupta 2016). Numerous inorganic (e.g. 
metal and metal oxides) and hybrid (e.g. biopolymer/polymer and metal) NPs have been generated to 
inhibit planktonic and biofilm growth of medically relevant Gram-positive and Gram-negative bacterial 
strains (Petkova and Francesko 2014;Sirelkhatim and Mahmud 2015;Wang and Gupta 2016;Wang and 
Hu 2017). The mechanisms underlying the metal NPs action, for example, in most cases occur 
simultaneously and comprise oxidative stress induction, metal ion release, and non-oxidative mechanisms 
including cell membrane disruption, penetration in bacterial cells and interactions with DNA, ribonucleic 
acid and proteins (Feng and Wu 2000;Pelgrift and Friedman 2013). The multiple bactericidal mechanisms 
require multiple simultaneous gene mutations and therefore for bacteria is very difficult to develop 
resistance (Pelgrift and Friedman 2013). For example, silver NPs (AgNPs), synthesised from the cell-free 
filtrate of fungus Rhizopus Oryzae, were able to interact with bacterial membrane, changing its 
penetrability (Ramalingam and Parandhaman 2016). In addition, the generated reactive oxygen species 
(ROS) interfered with the antioxidant defence system in bacteria, leading to damage of the E. coli and P. 
aeruginosa cells membrane (Ramalingam and Parandhaman 2016). Implants functionalized with 
antibacterial AgNPs resisted bacterial cells attachment in vivo demonstrating their potential in controlling 
bacterial infection (Secinti and Özalp 2011). ZnO NPs-coated medical textiles with durable antibacterial 
activity towards Gram-positive S. aureus and Gram-negative E. coli have been reported (Petkova and 
Francesko 2016). ZnO and copper oxide (CuO) NPs have been generated to inhibit planktonic or biofilm 
growth of E. coli, S. aureus and Bacillus subtilis and fungus Candida albicans via generation of ROS 
(Eshed and Lellouche 2012). CuO NPs been used for the development of broad-spectrum durable 
antibacterial coating towards E. coli, S. aureus and kanamycin-resistant E. coli (Li and Gao 2017). Zn-
doped CuO NPs with synergistic efficacy towards multidrug-resistant S. aureus and E. coli have been 
generated in situ and then deposited on silicone catheters (Malka and Perelshtein 2013;Shalom and 
Perelshtein 2017). In another work, ZnO/gold NPs generated increased ROS levels and demonstrated 
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improved antibacterial activity (He and Kim 2014). Doping the ZnO with fluorine also led in more ROS 
generation than the ZnO NPs and consequently greater bactericidal activity on S. aureus (99.99%) and E. 
coli (99.87%) (Podporska-Carroll and Myles 2017). Stable magnesium fluoride (MgF2) NPs coatings 
have been developed on silicone catheters and inhibited the E. coli and S. aureus biofilms (Lellouche and 
Friedman 2012). MgF2 NPs have been further combined with ZnO NPs and synergistically inhibited the 
resistant biofilm growth of Streptococcus pneumoniae and S. aureus on cochlear implants (Natan and 
Edin 2016). Antibacterial NPs of cationic biopolymer showed promising antibacterial activities. Thiolated 
chitosan and aminocellulose NPs showed increased cationic charge density and improved the bactericidal 
efficacy of the biopolymers towards Gram-negative pathogens (Fernandes and Francesko 2014). 
Furthermore, the NPs deposition either in layer-by-layer fashion or via chemical grafting onto silicone 
surface led to stable antibacterial and anti-biofilm active coatings (Fernandes and Ivanova 
2017;Francesko and Fernandes 2016).  
Nowadays, the design of hybrid polymer/biopolymer-metal NPs have appeared as attractive way to 
improve metal NPs biocompatibility, stability and efficacy in a safety-by-design way (Marambio-Jones 
and Hoek 2010). PEG-capped ZnO NPs with higher antimicrobial efficacy have been reported. ZnO NPs 
alone and in combination with the polymer killed the common pathogens and inhibited the resistant 
biofilm formation (Meruvu and Vangalapati 2011). Medical textiles have been coated with hybrid NPs of 
ZnO and the biopolymer chitosan to impart higher antibacterial functionality than the individual ZnO and 
chitosan coatings. Importantly, the inclusion of the biocompatible polymer in the hybrid NP coatings 
diminished the side effect of the metal to human cells in a safe manner (Petkova and Francesko 2014). 
Polymer-Ag bromide NPs and hydrogels loaded with AgNPs have been generated to completely inhibit 
the planktonic and biofilm bacterial growth (Agnihotri and Mukherji 2012;Sambhy and MacBride 2006). 
Enzymatically grafted hybrid Ag/chitosan NP coating inhibited S. aureus and E. coli bacterial growth and 
attachment onto cork surface (Francesko and Blandón 2015).  
Nevertheless the high antibacterial activity and the improved biocompatibility in vitro, the in vivo 
application of the aforementioned hybrid nanomaterials is scarcely studied. Nanotransformation of the 
existing antibiotics could be a facile approach to give new life to these old antibacterials instead of 
screening for new drugs. Unlike the most common strategies that rely on analogues with similar structural 
and functional characteristics to the original drug, the nano-sized transformation will improve the actives 
antibacterial efficacy by a mechanism comprised of a mechanical disruption of bacterial membrane and 
specific antibiotic activity. 
For example, NPs of β-lactam antibiotic penicillin have been produced using ultrasound sonochemistry. 
The NPs showed great antibacterial activity against clinical isolate of S. aureus (Yariv and Lipovsky 
2015). The nano-sized transformation of another antibiotic TET also improved its bactericidal activity, 
killing both TET sensitive and resistant bacteria (Shimanovich and Lipovsky 2015). Sonochemically 
synthesised graphene oxide/TET nanocomposites demonstrated enhanced activity against both sensitive 
and resistant S. aureus when compared to the same concentration of non-transformed antibiotic (Mishra 
and Segal 2015). TET loaded in protein microspheres showed high bactericidal effect against E. coli and 
S. aureus (Avivi and Nitzan 2003). Liposomes have also been used as carriers to improve the antibacterial 
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or anti-biofilm efficiency of several antibiotics, such as amikacin (Okusanya and Bhavnani 2009), 
ciprofloxacin, meropenem, and gentamicin (Gubernator and Drulis-Kawa 2007). However, the effective 
drug delivery by liposomes, which are composed on membrane phospholipids is very challenging task, 
due to drug leakage, temperature sensitivity, and short shelf-life. Several studies have shown that superior 
efficacy of in vivo cellular delivery, enhanced biocompatibility and prolonged circulation time can be 
achieved by lipid–polymer hybrid NPs compared with delivery without polymeric NPs or by liposomes. 
For instance, lipid-polymer hybrid NPs of norfloxacin have been prepared to eliminate S aureus and P. 
aeruginosa (Dave and Yadav 2017).  
 
Conclusions  
Overall, the development of effective strategies to fight bacterial infection while limiting the appearance 
of new drug resistant strains is a very challenging task. Despite we described very promising examples 
(summarised in Table 1), a better understanding of the antibacterial mechanism is required especially 
within the in vivo context in order to reach the final end users. Within the host environment, the 
uncontrolled protein adsorption onto the material can modify its physicochemical properties and 
antimicrobial efficacy by hindering its targeting capacity or inducing rapid clearance. Moreover, most of 
the highly effective antibacterial show low biocompatibility, which arises the need for development of a 
new generation of hybrid materials with strong antimicrobial/antifouling activities and improved 
biocompatibility generated in a “safety by design” manner. Finally, considering the bacterial genetic 
plasticity to evolve rapidly and survive hostile conditions a deep understanding of how bacteria can 
overcome the new antimicrobials is necessary to avoid its rapid obsolescence ending up once again 
without responses against resistant bacteria.  
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Figures 1 Strategies to prevent AMR precluding the design and development of different advanced 
materials. Anti-infective strategies to suppress the expression of virulence factors and prevent biofilm 
growth can be divided into i) anti-quorum sensing (anti-QS), ii) anti-toxins, and iii) antibiofouling (left 
side). Novel antibiotic alternatives aimed at killing pathogens via non-specific mechanisms related to 
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membrane damage, oxidative stress and interaction with genetic material and protein, reducing the 
possibility of inducing resistance in bacteria (right side).  
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Table 1: Advanced anti-infective and antibacterial strategies  
Anti-infective strategies 
Approach Actives Target References 
Anti-quorum sensing 
QQE: acylase and lactonase 
 Gram-negative bacteria 
Johansen and Falholt 1997 
Craigen and Dashiff 2011 
Ivanova and Fernandes 2015 
Grover and Plaks 2016 
Autoinducers analogues S. aureus Kratochvil and Tal-Gan 2015 
β-cyclodextrin functionalised NPs  V. fisheri Miller and Wang 2015 
Heterocyclic organic furanones: free form and encapsulated 
 
S. liquefaciens, P. mirabilis, E. 
coli and S. aureus 
Givskov and de Nys 1996 
Gram and de Nys 1996 
Ren and Sims 2001 
Cheng and Wu 2012 
Cheng and Zhao 2015 
 Synthetic furanones P. aeruginosa and S. epidermidis 
Wu and Song 2004 
Hume and Baveja 2004 
Toxin sequestering 
materials Polymer NPs coated with red blood cell membrane  
S. aureus, E. coli, S. 
pneumoniae, 
Henry and Neill 2014 
Wang and Gao 2015 
Thamphiwatana and Angsantikul 2017 
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Anti-infective strategies 
Approach Actives Target References 
Antibiofouling and 
antibiofilm surfaces  
Silver and titanium oxide nanofilms S. mutans Ghasemi and Arash 2017 
Fluoroalkylsilane S. epidermidis Tang and Cao 2009 
Negatively charged surfaces Gram-negative and -positive bacteria Boudou and Crouzier 2010 
Zwitterionic polymers E. coli, P. mirabilis, P. pseudomonas, S. aureus 
Cheng and Li 2009 
Chen and Li 2010 
Zhang and Chiao 2015 
Guo and Jańczewski 2015 
Diaz Blanco and Ortner 2014 
Alves and Magalhães 2016 
 
Deoxyribonuclease I P. aeruginosa and S. aureus Baelo and Levato 2015 Alves and Magalhães 2016 
Disersin B  S. epidermidis Pavlukhina and Kaplan 2012 
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Antibacterial strategies 
Approach Actives Target References 
Antibacterial enzymes 
Cellobiose dehydrogenase 
Gram-positive and -negative 
bacteria, including multidrug- 
resistant strains 
Walker and Fourgialakis 2007 
Ge and Zhao 2012 
Nyanhongo and Sygmund 2013 
Thallinger and Argirova 2014 
Lipovsky and Thallinger 2015 
Horseradish peroxidase E. coli and S. aureus Amitai and Andersen 2009 
 Glucose oxidase E. coli and S. aureus Amitai and Andersen 2009 
Lysostaphin  Staphylococci genus Yeroslavsky and Girshevitz 2015 
Lysozyme Gram-positive and -negative bacteria 
Minier and Salmain 2005 
Muszanska and Busscher 2011 
Yuan and Wan 2011 
Antimicrobial peptides 
Cateslytin functionalized HA S. aureus and C. albicans Cado and Aslam 2013 
Tet213  S. aureus and P. gingivalis Shi and Liu 2015 
Cecropin-melittin NPs  
E. coli, S. aureus, P. 
aeruginosa, Klebsiella 
Pneumoniae, multidrug resistant 
E. coli and Staphylococcus 
haemolyticus  
Rai and Pinto 2016 
 
 Defensin-based AMP  S. aureus, S. epidermidis and P. aeruginosa Townsend and Williams 2017 
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Antibacterial strategies 
Approach Actives Target References 
 
Cationic polymers 
Chitosan   
 
Clinically relevant E. faecalis 
strains, P. aeruginosa 
Gram-positive and –negative 
bacteria 
Bratskaya and Marinin 2007 
Wang and Hong 2012 
Shirvan and Nejad 2014 
Quaternary ammonium salt of chitosan E. coli and S. aureus Graisuwan and Wiarachai 2012 
Triblock polycarbonate polymer combined with PEG and a 
tethering or adhesive functional block E. coli and S. aureus Voo and Khan 2015 
 
Polycarbonate/PEG hydrogels Clinically isolated multidrug-resistant bacteria Liu and Yang 2012 
Advanced nanostructured 
materials 
Silver NPs E. coli, S. aureus and P. aeruginosa 
Ramalingam and Parandhaman 2016 
Petkova and Francesko 2016 
ZnO NPs E. coli, S. aureus, B. subtilis and C. albicans Eshed and Lellouche 2012 
CuO NPs coatings E. coli, S. aureus and kanamycin-resistant E. coli Li and Gao 2017 
Zn-doped CuO NPs Multidrug-resistant E. coli and 
S. aureus 
Malka and Perelshtein 2013 
Shalom and Perelshtein 2017 
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Antibacterial strategies 
Approach Actives Target References 
Advanced nanostructured 
materials 
Fluorine-doped ZnO NPs S. aureus and E. coli Podporska-Carroll and Myles 2017 
MgF2 coatings E. coli and S. aureus 
Lellouche J, Friedman A, Lahmi R, 
Gedanken A, Banin E 2012 
Hybrid MgF2/ZnO NPs S. pneumoniae and S. aureus Natan and Edin 2016 
Thiolated chitosan and aminocellulose NPs E. coli and P. aeruginosa 
Fernandes and Francesko 2014 
Francesko and Fernandes 2016 
Fernandes and Ivanova 2017 
Hybrid polymer/biopolymer-metal NPs S. aureus and E. coli 
Kishen and Shi 2008 
Francesko and Blandón 2015 
Petkova and Francesko 2014 
Penicillin NPs Clinical isolate of S. aureus Yariv and Lipovsky 2015 
TET nanoformulations  
Drug resistant and sensitive 
Gram-positive and Gram-
negative bacteria 
Avivi and Nitzan 2003 
Shimanovich and Lipovsky 2015 
Mishra and Segal 2015 
 
 Lipid-polymer hybrid NPs of norfloxacin S aureus and P. aeruginosa Dave and Yadav 2017 
 
